Journal of Rheumatic Diseases

Cited by CrossRef (14)

  1. Young Ho Lee, Gwan Gyu Song. A network meta-analysis of randomized controlled trials comparing the effectiveness and safety of voclosporin or tacrolimus plus mycophenolate mofetil as induction treatment for lupus nephritis. Z Rheumatol 2023;82:580
    https://doi.org/10.1007/s00393-021-01087-z
  2. Young Ho Lee, Gwan Gyu Song. Relative remission rates of Janus kinase inhibitors in comparison with adalimumab in patients with active rheumatoid arthritis: a network meta-analysis. Z Rheumatol 2024;83:88
    https://doi.org/10.1007/s00393-022-01165-w
  3. Young Ho Lee, Gwan Gyu Song. Associations between interleukin 17A and 17F polymorphisms and asthma susceptibility: A meta‐analysis. Int J Immunogenetics 2023;50:53
    https://doi.org/10.1111/iji.12611
  4. Young Ho Lee, Gwan Gyu Song. Comparative efficacy and safety of infliximab and its biosimilars in patients with rheumatoid arthritis presenting an insufficient response to methotrexate. Z Rheumatol 2023;82:114
    https://doi.org/10.1007/s00393-021-01040-0
  5. Young Ho Lee, Gwan Gyu Song. Efficacy and safety of tacrolimus versus mycophenolate mofetil as induction treatment and low-dose tacrolimus as treatment for lupus nephritis: a meta-analysis. Z Rheumatol 2023;82:754
    https://doi.org/10.1007/s00393-022-01313-2
  6. Rawan A. Nijeeb, Adnan A. Aljber, Ali H. Ad’hiah. Exon 2 variants (rs3811046 and rs3811047) of the IL37 gene are associated with susceptibility to systemic lupus erythematosus . Egyptian Journal of Basic and Applied Sciences 2024;11:269
    https://doi.org/10.1080/2314808X.2024.2336702
  7. Young Ho Lee, Gwan Gyu Song. Comparative Efficacy and Safety of Tacrolimus, Cyclosporin A, Mycophenolate Mofetil, Cyclophosphamide, and Corticosteroids as Induction Therapy for Membranous Lupus Nephritis: A Network Meta-Analysis. Pharmacology 2022;107:439
    https://doi.org/10.1159/000525066
  8. Entsar R. Mokhtar, Doaa Aly Abd El-Fattah, Neama R. Hussein, Heba Elhakeem, Lamia A. Gad, Eman Fekry Mohamed, Rehab Abd Elfattah Mohammed, Sammar Ahmed Kasim, Sara M. Elhadad, Marwa Mohamed M. Ali Abd El Rahim, Maha S. Mohamed, Mohamed Sobhy Mahmoud Rezk, Doaa Fathy, Nadia M. Hamdy, Hekmat M. El Magdoub. FCGR1A(CD64) expression on monocyte subsets and FIL1Z(IL-37) serum level as biomarkers of rheumatoid arthritis activity: A case controlled study and in silico analysis. Pathology - Research and Practice 2025;269:155910
    https://doi.org/10.1016/j.prp.2025.155910
  9. Nesreen M. Aboraia, Aliaa A. Ali, Amal T. Abdel-Rahman, Omayma O. Abdelaleem. Serum interleukin-37 and its gene polymorphism (rs3811047) in Egyptian patients with alopecia areata. Gene Reports 2025;38:102122
    https://doi.org/10.1016/j.genrep.2024.102122
  10. Yun-Hee Han, Hyeon-Jun Woo, Soo-Yeon Park, Chang-Hoon Lee, Chong-Hyuk Chung, Myeung-Su Lee, Jung-Han Lee. Korean Domestic Trends in Clinical Research on Rheumatoid Arthritis since 2008. J Korean Med Rehabil 2021;31:18
    https://doi.org/10.18325/jkmr.2021.31.3.19
  11. Yoon-Kyoung Sung, Young Ho Lee. Placebo and nocebo responses in randomized controlled trials of Janus kinase inhibitor monotherapy for rheumatoid arthritis. Z Rheumatol 2022;81:430
    https://doi.org/10.1007/s00393-021-00969-6
  12. Young Ho Lee. Comparative Efficacy and Safety of Janus Kinase Inhibitors and Secukinumab in Patients with Active Ankylosing Spondylitis: A Systematic Review and Meta-Analysis. Pharmacology 2022;107:537
    https://doi.org/10.1159/000525627
  13. Young Ho Lee, Gwan Gyu Song. Comparative efficacy and safety of adalimumab biosimilars and adalimumab in patients with rheumatoid arthritis presenting an insufficient response to methotrexate: a network meta-analysis. Z Rheumatol 2023;82:64
    https://doi.org/10.1007/s00393-021-01013-3
  14. Ali Saad Kadhim, Abdullah Salim Al-Karawi. Investigating the multifactorial correlation between obesity and rheumatoid arthritis: A study of immunological and biochemical markers. Obesity Medicine 2025;53:100578
    https://doi.org/10.1016/j.obmed.2024.100578